Traversing the genomic landscape of prostate cancer from diagnosis to death.
The clinical spectrum of prostate cancer ranges from curable, local disease to widely metastatic, lethal cancer. Two new prostate cancer genome studies provide the first glimpse at both ends of this spectrum.
Haley
H
Hieronymus
Charles L
CL
Sawyers
D051541:Hepatocyte Nuclear Factor 3-alpha / Q000235:genetics*; D006801:Humans; D008297:Male; D056892:Mediator Complex / Q000235:genetics*; D008869:Microtubule-Associated Proteins / Q000235:genetics*; D009154:Mutation; D011471:Prostatic Neoplasms / Q000235:genetics*
C496499:FOXA1 protein, human; D051541:Hepatocyte Nuclear Factor 3-alpha; C491894:MAP6 protein, human; C460107:MED12 protein, human; D056892:Mediator Complex; D008869:Microtubule-Associated Proteins